89
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Systemic lupus erythematosus associated with RASopathy

, , , , , & show all
Pages 94-98 | Received 24 Mar 2017, Accepted 29 May 2017, Published online: 22 Jun 2017

References

  • Klein-Gitelman M, Lane JC. Systemic lupus erythematosus. In: Petty RE, Laxer RM, Lindsley CB, editors. Textbook of pediatric rheumatology. 7th ed. Philaderphia (PA): WB Saunders; 2016. p. 285–317.
  • Webb R, Kelly JA, Somers EC, et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann Rheum Dis. 2011;70:151–156.
  • van der Burg I. Noonan syndrome. Orphanet J Rare Dis. 2007;2:4.
  • Aoki Y, Niihori T, Narumi Y, et al. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat. 2008;29:992–1006.
  • Bader-Meunier B, Cavé H, Jeremiah N, et al. Are RASopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus? Case report and systematic review of the literature. Semin Arthritis Rheum. 2013;43:217–219. Epub 2013 Jun 17.
  • Romano AA, Allanson JE, Dahlgren J, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2010;126:746–759.
  • Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011; 25:161–179.
  • Bezniakow N, Gos M, Obersztyn E. The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes. Dev Period Med. 2014;18:285–296.
  • Oliveira JB, Bidère N, Niemela JE, et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci USA. 2007;104:8953–8958.
  • Watanabe N. A summarization of the clinical studies for children with systemic lupus erythematosus by the Japanese Ministry of Health and Welfare study group: an annual report in 1985. In: Ueta Y, editor. A study for diagnosis and treatment in children with collagen diseases in Japan. Tokyo (Japan): Japanese Ministry of Health and Welfare; 1985. p. 9–14.
  • Quaio CR, Carvalho JF, ds Silva CA, et al. Autoimmune disease and multiple autoantibodies in 42 patients with rasopathies. Am J Med Genet. 2012;158A:1077–1082.
  • Niemela JE, Lu L, Fleisher TA, et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood. 2011;117:2883–2886.
  • Takagi M, Shinoda K, Piao J, et al. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood. 2011;117:2887–2890.
  • Alanay Y, Balci S, Ozen S. Noonan syndrome and systemic lupus erythematosus: presentation in childhood. Clin Dysmorphol. 2004;13:161–163.
  • Martin DM, Gencyuz CF, Petty EM. Systemic lupus erythematosus in a man with Noonan syndrome. Am J Med Genet. 2001;102:59–62.
  • Amoroso A, Garzia P, Vadacca M, et al. The unusual association of three autoimmune diseases in a patient with Noonan syndrome. J Adolesc Health. 2003;32:94–97.
  • Lopez-Rangel E, Malleson PN, Lirenman DS, et al. Systemic lupus erythematosus and other autoimmune disorders in children with Noonansyndrome. Am J Med Genet. 2005;139:239–242.
  • Lisbona MP, Moreno M, Orellana C, et al. Noonan syndrome associated with systemic lupus erythematosus. Lupus. 2009;18:267–269.
  • Quaio CR, Carvalho JF, DaSilva CA, et al. Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies. Am J Med Genet A. 2012;158A:1077–1082.
  • Leventopoulos G, Denayer E, Makrythanasis P, et al. Noonan syndrome and systemic lupus erythematosus in a patient with a novel KRAS mutation. Clin Exp Rheumatol. 2010;28:556–557.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.